280 related articles for article (PubMed ID: 19362712)
21. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
22. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.
Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K
Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791
[TBL] [Abstract][Full Text] [Related]
23. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins.
Blumenthal A; Kobayashi T; Pierini LM; Banaei N; Ernst JD; Miyake K; Ehrt S
Cell Host Microbe; 2009 Jan; 5(1):35-46. PubMed ID: 19154986
[TBL] [Abstract][Full Text] [Related]
24. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Hölscher C; Reiling N; Schaible UE; Hölscher A; Bathmann C; Korbel D; Lenz I; Sonntag T; Kröger S; Akira S; Mossmann H; Kirschning CJ; Wagner H; Freudenberg M; Ehlers S
Eur J Immunol; 2008 Mar; 38(3):680-94. PubMed ID: 18266299
[TBL] [Abstract][Full Text] [Related]
25. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
26. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
Chang S; Dolganiuc A; Szabo G
J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
[TBL] [Abstract][Full Text] [Related]
29. The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.
Jeon JH; Lee HR; Cho MH; Park OK; Park J; Rhie GE
Infect Immun; 2015 Oct; 83(10):3847-56. PubMed ID: 26195551
[TBL] [Abstract][Full Text] [Related]
30. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.
Erdman LK; Cosio G; Helmers AJ; Gowda DC; Grinstein S; Kain KC
J Immunol; 2009 Nov; 183(10):6452-9. PubMed ID: 19864601
[TBL] [Abstract][Full Text] [Related]
31. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.
Yu X; Zeng J; Xie J
Biochimie; 2014 Jul; 102():1-8. PubMed ID: 24594065
[TBL] [Abstract][Full Text] [Related]
32. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
Henneke P; Takeuchi O; van Strijp JA; Guttormsen HK; Smith JA; Schromm AB; Espevik TA; Akira S; Nizet V; Kasper DL; Golenbock DT
J Immunol; 2001 Dec; 167(12):7069-76. PubMed ID: 11739528
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling.
Shin DM; Yuk JM; Lee HM; Lee SH; Son JW; Harding CV; Kim JM; Modlin RL; Jo EK
Cell Microbiol; 2010 Nov; 12(11):1648-65. PubMed ID: 20560977
[TBL] [Abstract][Full Text] [Related]
34. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling.
Su Q; Pfalzgraff A; Weindl G
J Steroid Biochem Mol Biol; 2017 Jul; 171():201-208. PubMed ID: 28377308
[TBL] [Abstract][Full Text] [Related]
35. Capsid proteins of foot-and-mouth disease virus interact with TLR2 and CD14 to induce cytokine production.
Lin YT; Chen YP; Fang CH; Huang PY; Liang SM
Immunol Lett; 2020 Jul; 223():10-16. PubMed ID: 32333963
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 1 variations influence susceptibility and immune response to Mycobacterium tuberculosis.
Dittrich N; Berrocal-Almanza LC; Thada S; Goyal S; Slevogt H; Sumanlatha G; Hussain A; Sur S; Burkert S; Oh DY; Valluri V; Schumann RR; Conrad ML
Tuberculosis (Edinb); 2015 May; 95(3):328-35. PubMed ID: 25857934
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium tuberculosis 19-kDa lipoprotein induces Toll-like receptor 2-dependent peroxisome proliferator-activated receptor γ expression and promotes inflammatory responses in human macrophages.
Liu L; Liu J; Niu G; Xu Q; Chen Q
Mol Med Rep; 2015 Apr; 11(4):2921-6. PubMed ID: 25504154
[TBL] [Abstract][Full Text] [Related]
38. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
39. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional and inflammasome-mediated pathways for the induction of IL-1beta production by Mycobacterium tuberculosis.
Kleinnijenhuis J; Joosten LA; van de Veerdonk FL; Savage N; van Crevel R; Kullberg BJ; van der Ven A; Ottenhoff TH; Dinarello CA; van der Meer JW; Netea MG
Eur J Immunol; 2009 Jul; 39(7):1914-22. PubMed ID: 19544485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
